"Hepatic carcinoma" trang 1 - tải miễn phí từ tailieunhanh
Advanced hepatocellular carcinoma with hepatic vein tumor thrombosis and renal dysfunction after hepatic arterial infusion chemotherapy effectively treated by liver resection with active veno-venous bypass: Report of a case

Advanced hepatocellular carcinoma with hepatic vein tumor thrombosis and renal dysfunction after hepatic arterial infusion chemotherapy effectively treated by liver resection with active veno-venous bypass: Report of a case
7    42    1
Paracrine effects of CCN3 from noncancerous hepatic cells increase signaling and progression of hepatocellular carcinoma

Paracrine effects of CCN3 from noncancerous hepatic cells increase signaling and progression of hepatocellular carcinoma
10    92    0
Remodeling of hepatic stellate cells orchestrated the stroma-derived oxaliplatin-resistance through CCN3 paracrine in hepatocellular carcinoma

Remodeling of hepatic stellate cells orchestrated the stroma-derived oxaliplatin-resistance through CCN3 paracrine in hepatocellular carcinoma
11    48    0
Randomized, phase II trial of sequential hepatic arterial infusion chemotherapy and sorafenib versus sorafenib alone as initial therapy for advanced hepatocellular carcinoma: SCOOP-2 trial

Randomized, phase II trial of sequential hepatic arterial infusion chemotherapy and sorafenib versus sorafenib alone as initial therapy for advanced hepatocellular carcinoma: SCOOP-2 trial
10    87    0
Survival benefit of hepatic resection versus transarterial chemoembolization for hepatocellular carcinoma with portal vein tumor thrombus: A systematic review and meta-analysis

Survival benefit of hepatic resection versus transarterial chemoembolization for hepatocellular carcinoma with portal vein tumor thrombus: A systematic review and meta-analysis
14    59    1
Comparison of hepatic resection and transarterial chemoembolization for UICC stage T3 hepatocellular carcinoma: A propensity score matching study

Comparison of hepatic resection and transarterial chemoembolization for UICC stage T3 hepatocellular carcinoma: A propensity score matching study
10    79    1
The role of clinically significant portal hypertension in hepatic resection for hepatocellular carcinoma patients: A propensity score matching analysis

The role of clinically significant portal hypertension in hepatic resection for hepatocellular carcinoma patients: A propensity score matching analysis
11    42    1
A nomogram based on combining systemic and hepatic inflammation markers for predicting microscopic bile duct tumour thrombus in hepatocellular carcinoma

A nomogram based on combining systemic and hepatic inflammation markers for predicting microscopic bile duct tumour thrombus in hepatocellular carcinoma
9    44    1
Pembrolizumab plus lenvatinib with or without hepatic arterial infusion chemotherapy in selected populations of patients with treatment-naive unresectable hepatocellular carcinoma exhibiting PD-L1 staining: A multicenter retrospective study

Pembrolizumab plus lenvatinib with or without hepatic arterial infusion chemotherapy in selected populations of patients with treatment-naive unresectable hepatocellular carcinoma exhibiting PD-L1 staining: A multicenter retrospective study
13    52    1
HEPATIC SURGERY_2

HEPATIC SURGERY_2
318    57    0
HEPATIC SURGERY_1

HEPATIC SURGERY_1
336    50    0
The prognostic significance of serum gamma-glutamyltransferase levels and AST/ ALT in primary hepatic carcinoma

The prognostic significance of serum gamma-glutamyltransferase levels and AST/ ALT in primary hepatic carcinoma
9    102    0
Hepatic arterial infusion chemotherapy followed by sorafenib in patients with advanced hepatocellular carcinoma (HICS 55): An open label, non-comparative, phase II trial

Hepatic arterial infusion chemotherapy followed by sorafenib in patients with advanced hepatocellular carcinoma (HICS 55): An open label, non-comparative, phase II trial
10    84    1
Association of IFNL3 genotype with hepatic steatosis in chronic hepatitis C patients treated with peginterferon and ribavirin combination therapy

Association of IFNL3 genotype with hepatic steatosis in chronic hepatitis C patients treated with peginterferon and ribavirin combination therapy
6    86    0
Circulatory miRNA-484, 524, 615 and 628 expression profiling in HCV mediated HCC among Egyptian patients; implications for diagnosis and staging of hepatic cirrhosis and fibrosis

Circulatory miRNA-484, 524, 615 and 628 expression profiling in HCV mediated HCC among Egyptian patients; implications for diagnosis and staging of hepatic cirrhosis and fibrosis
10    91    0
Patients with hepatic breast cancer metastases demonstrate highly specific profiles of matrix metalloproteinases MMP-2 and MMP-9 after SIRT treatment as compared to other primary and secondary liver tumours

Patients with hepatic breast cancer metastases demonstrate highly specific profiles of matrix metalloproteinases MMP-2 and MMP-9 after SIRT treatment as compared to other primary and secondary liver tumours
11    83    1
Effect of microwave ablation treatment of hepatic malignancies on serum cytokine levels

Effect of microwave ablation treatment of hepatic malignancies on serum cytokine levels
10    91    1
A case report of hepatic perivascular epithelioid cell tumours (pecomas) and literature review

A case report of hepatic perivascular epithelioid cell tumours (pecomas) and literature review
4    44    1
Persistent hepatic inflammation plays a role in hepatocellular carcinoma after sustained virological response in patients with HCV infection

Persistent hepatic inflammation plays a role in hepatocellular carcinoma after sustained virological response in patients with HCV infection
9    62    0
The prognostic value of cytokeratin and sal-like protein 4 expression in hepatocellular carcinoma and intra-hepatic cholangiocarcinoma in Taiwan

The prognostic value of cytokeratin and sal-like protein 4 expression in hepatocellular carcinoma and intra-hepatic cholangiocarcinoma in Taiwan
11    60    0